multiple sclerosis tagged posts

Experimental drug reverses paralysis and vision loss in multiple sclerosis model

nerve
Credit: Pixabay/CC0 Public Domain
A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of multiple sclerosis. The results are striking because existing MS treatments are designed to reduce future inflammatory attacks, not restore neurological function already lost.

A drug developed by a UVA Health scientist has not only stopped but reversed paralysis and vision loss in a mouse model of multiple sclerosis. The results are striking because existing MS treatments are designed to reduce future inflammatory attacks, not restore neurological function already lost.

The research is published in the journal Science Translational Medicine.

The drug, Kamuvudine K-9, is a derivative of HIVdrugs already approved for use in peop...

Read More

Scientists discover New T cells and Genes related to Immune Disorders

A newly developed method called ReapTEC allowed the discovery of thousands of active bidirectional enhancers. Further analysis of GWAS data revealed that various immune-mediated diseases, like multiple sclerosis and rheumatoid arthritis, are related to genetic variations within these enhancers.

Researchers led by Yasuhiro Murakawa at the RIKEN Center for Integrative Medical Sciences (IMS) and Kyoto University in Japan and IFOM ETS in Italy have discovered several rare types of helper T cells that are associated with immune disorders such as multiple sclerosis, rheumatoid arthritis, and even asthma...

Read More

Epstein-Barr Virus and Brain Cross-reactivity: Possible mechanism for Multiple Sclerosis detected

53583781808_8a136fefe6_o
Source: NIAID
An electron micrograph showing three Epstein-Barr virus (EBV) particles colorized red-orange.

The role that Epstein-Barr virus (EBV) plays in the development of multiple sclerosis (MS) may be caused by a higher level of cross-reactivity, where the body’s immune system binds to the wrong target, than previously thought.

In a new study published in PLOS Pathogens, researchers looked at blood samples from people with MS, as well as healthy people infected with EBV and people recovering from glandular fever caused by recent EBV infection.

The study investigated how the immune system deals with EBV infection as part of worldwide efforts to understand how this common virus can lead to the development of multiple sclerosis, following 20 years of mounting evidence showing a...

Read More

Signs of Multiple Sclerosis show up in Blood Years Before Symptoms, study finds

An illustration of antibodies attacking a cell.

In a discovery that could hasten treatment for patients with multiple sclerosis (MS), UC San Francisco scientists have discovered a harbinger in the blood of some people who later went on to develop the disease.

In about 1 in 10 cases of MS, the body begins producing a distinctive set of antibodies against its own proteins years before symptoms emerge. These autoantibodies appear to bind to both human cells and common pathogens, possibly explaining the immune attacks on the brain and spinal cord that are the hallmark of MS.

The findings were published in Nature Medicine on April 19.

MS can lead to a devastating loss of motor control, although new treatments can slow the progress of the disease and, for example, preserve a patient’s ability to walk...

Read More